Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Authors
Keywords
Glioblastoma, Temozolomide (TMZ), O(6)-Methylguanine-DNA methyltransferase (MGMT), Methylation specific PCR (MSP), Pyrosequencing (PSQ), IDH (isocitrate dehydrogenase)
Journal
Acta Neuropathologica Communications
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-05
DOI
10.1186/s40478-019-0745-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
- (2018) David Capper et al. ACTA NEUROPATHOLOGICA
- MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.
- (2018) Monika E Hegi et al. CLINICAL CANCER RESEARCH
- ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial
- (2017) Ulrich Herrlinger et al. NEURO-ONCOLOGY
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Assessment of Quantitative and AllelicMGMTMethylation Patterns as a Prognostic Marker in Glioblastoma
- (2016) Lasse S. Kristensen et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial
- (2016) Bogdana Suchorska et al. NEURO-ONCOLOGY
- The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
- (2016) Hailong Zhao et al. World Journal of Surgical Oncology
- Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial
- (2016) Véronique Quillien et al. Oncotarget
- Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma
- (2016) Nicole R. Parker et al. Scientific Reports
- MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
- (2015) M. Weller et al. CLINICAL CANCER RESEARCH
- Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions
- (2015) Michal Bienkowski et al. CLINICAL NEUROPATHOLOGY
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
- (2014) Véronique Quillien et al. JOURNAL OF NEURO-ONCOLOGY
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
- (2012) Arne Christians et al. PLoS One
- Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
- (2011) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
- (2009) J Dunn et al. BRITISH JOURNAL OF CANCER
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods
- (2009) Lucie Karayan-Tapon et al. JOURNAL OF NEURO-ONCOLOGY
- Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces
- (2009) Minghong Jiang et al. LABORATORY INVESTIGATION
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Errors in the bisulfite conversion of DNA: modulating inappropriate- and failed-conversion frequencies
- (2008) D. P. Genereux et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now